PS433540: Clinical Trials

2 completed. 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	2	Completed 2

Follow PS433540: new trials by email Literature Review of PS433540 trials Research Report on PS433540

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study To Evaluate The Dose-Related Efficacy and Safety of PS433540 in Subjects With Hypertension irbesartan, placebo, PS433540 - Hypertension	Phase 2	Completed	Ligand Pharmaceuticals	261	2008-03-01	2011-09-16
A Trial to Evaluate the Safety and Efficacy of PS433540 to Treat Hypertension PS433540, placebo - Hypertension	Phase 2	Completed	Ligand Pharmaceuticals	280	2007-08-01	2011-09-16

Conditions studied

Hypertension (2)

Sponsors

Ligand Pharmaceuticals (2)

Countries

United States (2)

Top investigators

Joel M Neutel, MD (1)  ·  Joel Neutel, MD (1)  ·  Rene Belder, MD (1)